|Day Low/High||36.34 / 36.77|
|52 Wk Low/High||33.97 / 46.47|
Sangamo Therapeutics, Inc. (NASDAQ: SGMO), a genomic medicine company, and Pfizer, Inc.
- Q4 share repurchases increased 62.8% year-over-year to a record $223.0 billion
Pfizer pays $51 million up front for a 15% stake in French biopharmaceutical company Vivet.
Vivet Therapeutics ("Vivet"), a privately held gene therapy biotech company dedicated to developing gene therapy treatments for inherited liver disorders with high unmet medical need, and Pfizer Inc.
Pfizer Inc. invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.
Jim Cramer explains the art and science of technical analysis.
The Bristol-Myers Squibb- Pfizer Alliance today announced results from the Phase 4 AUGUSTUS trial evaluating Eliquis ® (apixaban) versus vitamin K antagonists (VKAs) in patients with non-valvular atrial fibrillation (NVAF) and recent acute coronary...
A study of analyst recommendations at the major brokerages shows that Pfizer Inc is the #14 broker pick, on average, out of the 30 stocks making up the Dow Jones Industrial Average, according to ETF Channel. Within the broader S&P 500, when components were ranked in terms of analyst favorites, PFE claims the #258 spot.
Pfizer Inc. (NYSE: PFE) today announced the United States (U.
Allergan is another stock that could stay stuck in its Doldrums. See which of its peers Jim Cramer likes better and why.
The Dow Jones Industrial Average ended the day lower as details over the trade talks between the U.S. and China are awaited and oil prices tumble.
Pfizer Inc. invites investors and the general public to view and listen to a webcast of a presentation by Andy Schmeltz, Global President, Oncology, and Chris Boshoff, Chief Development Officer, Oncology, at the Cowen and Company 39 th Annual Healthcare...
Pfizer Inc. (NYSE: PFE) today announced the pricing of a debt offering consisting of five tranches of notes: $500,000,000 aggregate principal amount of 2.
Pfizer today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for LORVIQUA ® (lorlatinib, approved in the U.
The most recent short interest data has been released for the 02/15/2019 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Dow Jones Industrial Average by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.
Pfizer Inc. (NYSE: PFE) announced today the new serotypes included in its 20-Valent pneumococcal conjugate vaccine (20vPnC) candidate, PF-06482077, being investigated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae...
Johnson & Johnson says it will comply with the subpoenas for information related to its iconic baby powder.
Ochsner Health System, Louisiana's largest non-profit academic healthcare system, and Pfizer Inc (NYSE:PFE) have entered into a multi-year strategic alliance to develop innovative models for clinical trials.
Pfizer Inc. (NYSE: PFE) today announced the European Commission (EC) has approved ZIRABEV™ for the treatment of metastatic carcinoma of the colon or rectum, metastatic breast cancer, unresectable advanced, metastatic or recurrent non-small cell lung...
Pets can bring significant profits to companies that cater to this niche market.
Jim Cramer sees ripple effects of a storm of IPOs, and is worried about the lack of money coming into the market.
Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc.
The Dow Jones Industrial Average falls as investors eye progress in this week's renewed U.S.-China trade talks.
Don't get too bearish, says Jim Cramer, but don't break discipline here. This is a perfectly reasonable decline.
Dramatic showdown or appeal for unity? Trump seeks to 'heal old wounds, build new coalitions.'
Selecting the creme de la creme of last year's top dividend dogs generated an average total return of 8.8%.
Pfizer today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending Vizimpro® (dacomitinib) 45 mg, as monotherapy, be granted marketing authorization in...
Pfizer may be done with its two-month correction but the uptrend may not resume right away.
Kate Warne, investment strategist at Edward Jones, talked to TheStreet about what Boeing's report means for U.S. companies with exposure to China, Apple's beat and how the healthcare sector is looking.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.